Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Inclaudamab - ACC


64339 11/3 2013 11:17
Oversigt

Igår fik vi så lidt mere smag på Inclacumab.

fra 2.50 cirka.

We have a new target! It appears it really makes a difference. Concern about safety!

Lige på grænsen af p 0.05.

Vi skal have et større forsøg.

http://www.cardiosource.org/News-Media/Cardiosource-Video-News.aspx?vidid=w59UKuQTlkO6LWftXyS-KA

Late-Breaking Clinical Trials III: Chronic CAD/Stable Ischemic Heart Disease and Acute Coronary Syndromes
Session 302
Sunday, March 10, 10:45 a.m. - 12:15 p.m.
South, Esplanade Ballroom

The STREAM Trial
Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER Trial
Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
Randomized Comparison of High-dose Oral Vitamins vs. Placebo in the Trial to Assess Chelation Therapy
Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina (TERISA) randomized clinical trial



11/3 2013 11:20 064340



og her link fra Chat

http://www.theheart.org/article/1516411.do

He continued: ''This is still a pilot study with fewer than 600 patients-getting something definitive will take a much larger study. This, however, is the kind of study we should be doing: rationally based and scientific developed. This looks very promising, and I hope we get to see this in larger trials."



TRÅDOVERSIGT